Study of Side Effects and Treatment Response in Cancer Patients Receiving Anti-VEGF Therapies

What this Trial Is About

This research aims to observe the side effects and clinical responses in patients with advanced cancer treated with therapies related to anti-VEGF. The study focuses on patients with hematopoietic and lymphoid cell neoplasms or malignant solid neoplasms and seeks to understand any relationships between treatment side effects and disease response. It is a prospective observational study conducted by M.D. Anderson Cancer Center. Participants medical records are reviewed to gather information about complications and responses associated with anti-VEGF-related therapies. The study explores clinical complications, correlations between response rates and a novel blood pressure scoring system, and the validity of this new scoring method compared to standard adverse event criteria. No direct interventions are given as part of the study. During the study, researchers collect data from existing health records over up to five years, focusing on serious adverse events possibly related to treatment. They measure the incidence of grade 3 or higher side effects and assess correlations with clinical outcomes. The study does not involve active treatments or visits but uses retrospective data review to improve understanding of anti-VEGF therapy effects in cancer care.

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies